4 Firms Steer SPAC's $300M Israeli Medical Pot Co. Tie-Up
The second blank check company launched by cannabis investment firm Subversive Capital said Tuesday that it will take Israel's largest medical marijuana company public in a merger valuing it at $300...To view the full article, register now.
Already a subscriber? Click here to view full article